CRP and cancer: Along with other individual blood biomarkers (i.e., white cell count (WCC), albumin, C‐reactive protein (CRP) and lactate dehydrogenase (LDH) etc) or composite scores, such as the modified Glasgow Prognostic Score (mGPS), these inflammatory biomarkers are firmly established as having prognostic value in patients with cancer.11, 12, 13, 14